Navigation Links
Lombardi's Shields leads special journal focused on tobacco research
Date:12/3/2009

Washington, DC The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over.

The December issue of CEBP, a journal of the American Association for Cancer Research, is designed to provide researchers with the critical tools to conduct research directed to assisting decision-makers, such as those at the U.S. Food and Drug Administration (FDA), with a comprehensive review of the most up-to-date research on tobacco use. The journal includes nine review articles by leading experts in the field and covers topics from clinical trail design to how to best assess toxicity levels in new tobacco products. Shields is lead investigator for a series of papers in the issue.

"The FDA will soon grapple with very challenging issues," Shields says. "It cannot ban tobacco entirely, and its policy makers will need to address a unique paradigm -- how to regulate and balance health risks with continued protection of an industry whose products harm and kill people when used as intended."

Shields says the special issue of CEBP will provide the FDA and those who serve on the FDA's tobacco advisory panel with a strong scientific context to move tobacco regulation forward.

"Still, it is evident that not much scientific data are available to support the type of tobacco regulation that we would like to have today which could lead to a substantial drop in the tobacco-related diseases and deaths," Shields explains. "Perhaps this lack of data will help drive more funding for this under-researched area. These papers identify the strengths, limitations and research gaps for a wide spectrum of tobacco research methods."

The reviews in CEBP will also help inform future research by describing some of the strategies that might be applied when assessing differences in product risk and harms. Additionally, the issue features several studies on lung cancer in minorities, risk for experimentation, the impact of popular culture and the effect of alternative products like herbal cigarettes.

Shields he has served as an expert witness on behalf of plaintiffs in tobacco-related litigation.


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Research Reveals How Down Syndrome Shields Against Cancer
2. Vaccine Shields Monkeys From Simian Form of HIV
3. Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch COPPERTONE(R) NutraShield(TM) - New Sunscreen Contains Antioxidants That Promote Natural Skin Repair
4. Study Shows Exercise Shields Against Osteoporosis
5. Drug Shields Mice From Emphysema
6. Football helmet shields can protect against a kick in the face
7. Col. Robert E. Shields Joins Palmetto GBAs Board of Directors
8. Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose
9. Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls
10. Detroit Clinic Owner Pleads Guilty in Medicare Fraud Scheme
11. UT leads collaborative initiative for innovative cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader ... Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the ... their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling ...
(Date:3/28/2017)... ... 28, 2017 , ... Calibration, qualification, and the appropriate level ... maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO entitled ... these requirements are explained. The challenge is to determine how to put ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... ions found in power plant water and steam. , Chlorides and sulfates cause ... boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at low ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board Certified ... Integrative Medicine and available for application on Saturday, May 27, 2017, following Thursday, ... Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... -- Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), ... Christopher Gabrieli , partner ... chairman of the board of Akcea Therapeutics. ... Laboratories. Sandford D. Smith , founder ... "We are excited to announce this expansion to our board ...
(Date:3/28/2017)... ROCKVILLE, Md. , March 28, 2017 /PRNewswire/ ... dedicated to innovative therapeutics addressing cancer and other ... at the American Association for Cancer Research annual ... April 3 is entitled "Evaluation of ENMD-2076 ... and the second poster to be presented ...
(Date:3/28/2017)... 28, 2017 The global ... a value of USD 4.5 billion by 2025, according ... Proper closure of injured tissues post operation is a ... leakages occur in 3% to 15% of cases and ... for one third of postoperative deaths in patients. Surgical ...
Breaking Medicine Technology: